|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| G01N 33/574 | |||
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 2488553 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10766341.1 |
| Date of filing the European patent application | 2010-10-04 | |
| (97) | Date of publication of the European application | 2012-08-22 |
| (45) | Date of publication and mention of the grant of the patent | 2015-06-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2010/054465 |
| Date | 2010-10-04 |
| (87) | Number | WO 2011/045704 |
| Date | 2011-04-21 |
| (30) | Number | Date | Country code |
| 250711 P | 2009-10-12 | US |
| (72) |
HUANG, Bo, US
MARSHALL, Margaret Ann, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | CANCER TREATMENT |
| CANCER TREATMENT |